Last updated:
June 2026
When Biotech AI Workloads Belong in Dedicated Colocation
Discover when biotech AI workloads outgrow the cloud—and how dedicated colocation handles compliance, GPU demand, and petabyte-scale data.
Biotech
Biotech organizations that run AI workloads face infrastructure choices that the public cloud was not built to handle. For example, they may have petabyte-scale genomic datasets that cost more to move than to process. They may also face rules that require data to stay in a certain place. In addition, many teams run training all the time, so “pay as you go” pricing can become a risk instead of a benefit.
This analysis explains when dedicated colocation becomes the sensible choice for biotech AI. It covers the workload patterns that push teams away from shared cloud resources, the architecture needed for compliance-ready GPU clusters, and hybrid options that keep tight control of sensitive data while still allowing elastic capacity for experiments.
Biotech AI workloads that push organizations to colocation
Biotech AI is not the same as general enterprise AI, and those differences matter for infrastructure. These workloads often train all the time on proprietary datasets. At the same time, regulations may limit where that data can go. As a result, data gravity becomes a real issue when you manage petabytes of connected genomic, imaging, and clinical datasets.
Four workload patterns often push biotech teams toward dedicated infrastructure:
- Whole-slide pathology training: Digital pathology models process multi-terabyte image datasets and need repeat reprocessing as new slides arrive.
- Multi-omics foundation models: These combine genomics, transcriptomics, and proteomics data using shared feature stores that many teams use at the same time.
- Proprietary clinical datasets: Fine-tuning on patient data brings compliance rules where data residency is not optional.
- Closed-loop lab automation: AI agents that control lab instruments need stable, low latency that cloud environments cannot promise.
Consider this example: a biotech organization moves 5 petabytes each month while it runs nonstop retraining pipelines for three research teams. At that size, elastic compute can turn into a drawback. Instead, you need infrastructure that you can control and predict.
Cloud vs colocation decision points for biotech AI
At certain points, the costs and risks change. After those thresholds, dedicated infrastructure can beat on-demand cloud pricing.
GPU utilization patterns that favor dedicated capacity
If cluster-wide GPU use stays above 60% for long periods, the math changes. When GPUs run close to 24/7, reserved instance pricing may no longer help much. Also, when several teams share the same queues, demand stays steady, and dedicated capacity often serves that steady load better.
- Steady training pipelines: Ongoing model updates as new data arrives.
- Multiple team access: Research groups share one GPU cluster, with jobs queued all day and night.
- Recurring fine-tuning: Weekly model updates create stable, predictable compute demand.
Data movement costs that flip the equation
For data-heavy biotech workloads, network charges can be as large as compute charges. In addition, data gravity becomes the key issue when you keep “living” datasets that many teams use all the time. At that point, moving petabytes can cost more than placing compute next to the data.
Governance requirements that demand provable control
HIPAA, GDPR, GxP, and 21 CFR Part 11 bring audit needs that shared infrastructure can struggle to satisfy. These frameworks require immutable audit trails that record every access event. They also require validated change control, meaning every infrastructure change must follow documented steps.
When audits become part of delivery, infrastructure choices can affect product timelines. A failed audit can delay drug approval by months.
AI-ready colocation architecture for biotech workloads
The main goal is to keep GPUs supplied with data and to finish training runs on time. To do that, you need system-level design, not just a list of parts.
Power and cooling for high-density GPU clusters
Modern GPU clusters can need 50–150 kW per rack. By contrast, traditional servers often need only 5–10 kW per rack. Current NVIDIA H100 systems use about 700W per GPU, and next-generation platforms will go beyond 1000W per GPU.
At these power levels, direct liquid cooling (DLC) becomes necessary. Air cooling stops working well once racks go above 30 kW. DLC systems track supply temperature and flow rates all the time. Even small temperature swings can cause thermal throttling, which can cut Model FLOPS Utilization (MFU) by 15–20%.
- Power density planning: Plan for future platforms, not only today’s needs.
- Thermal monitoring: Record temperature and flow data every 30 seconds to support root-cause analysis.
- Facility stability: Stable power delivery helps prevent MFU drops that waste GPU cycles.
Networking fabric design for distributed training
Distributed training creates traffic patterns that normal networks do not handle well. In all-reduce operations, every GPU must exchange gradients with every other GPU. If the network is weak, tail latency rises, and then the whole cluster must wait.
InfiniBand can provide about 5-microsecond latency and fits these patterns well. Modern Ethernet options can reach similar results when configured correctly. The best choice depends on what you need:
- InfiniBand: Best for dedicated training clusters with stable communication patterns.
- Ethernet: Better for mixed workloads and multi-tenant environments.
Before you decide, benchmark your real software stack at a realistic scale. Otherwise, a poor topology can cut effective bandwidth by 40%.
Storage tiers that prevent GPU starvation
In biotech AI infrastructure, storage is often the most common bottleneck. GPUs can process data faster than many storage systems can supply it. Imaging workloads may need sustained bandwidth of 40–100 GB/s to keep GPU clusters busy.
Also, small-file performance matters as much as peak throughput in pathology. Training on millions of image files can require 100,000+ metadata operations per second, while still keeping high data throughput.
Hot/warm/cold tiering with clear lifecycle policies can lower costs while keeping performance:
- Hot (NVMe): 100 GB/s performance for active training datasets.
- Warm (SSD): 40 GB/s for recent experiments and validation data.
- Cold (HDD): 10 GB/s for archived results and compliance retention.
Compliance and security in biotech colocation
Compliance depends on proof, not just intent. You must log every relevant event, and you must run change management through validated steps.
Physical and logical security controls
SOC 2 Type II certification is the baseline for biotech colocation. On top of that, HIPAA-aligned designs add needs for encryption, access logs, and data retention.
Facility controls should match what auditors expect to see. For example, biometric access control, 24/7 monitoring, and mantrap entries help prevent unauthorized entry. Just as important, these controls create logs that auditors review to confirm compliance.
- Encryption requirements: Use FIPS-validated modules for data at rest and in transit.
- Key separation: Hardware Security Modules (HSMs) help ensure infrastructure operators cannot access encrypted data.
- Access boundaries: Clear ownership models define who controls encryption keys.
GxP and regulatory readiness
Good Clinical Practice (GxP) and 21 CFR Part 11 add more requirements than standard security. Every infrastructure change must follow written procedures with approval steps.
Validated operations mean the infrastructure acts the same way each time. Testing steps confirm systems work as specified. Documentation shows validation happened and that results met the requirements.
Immutable logs must capture every event, with timestamps synced to trusted sources. These logs must be kept for 7–10 years, and they must stay readable for that whole time.
Key insight: Compliance equals process plus evidence. Colocation can make compliance easier when the operator follows regulated runbooks and provides complete audit trails.
Hybrid colocation plus burst strategy
Organizations can keep control of sensitive data while still using elastic capacity for changing workloads. In this model, regulated data and steady training stay on dedicated infrastructure. Then, cloud capacity supports experiments and overflow.
In practice, the pattern splits workloads by compliance needs. Patient data, genomic sequences, and trained models stay in controlled colocation. Meanwhile, experiments that use synthetic data can run in the cloud.
Private interconnects link colocation and cloud without sending data over public networks. This also helps avoid unpredictable egress costs while keeping security strong. In addition, scheduling policies can favor data locality first and then optimize for cost.
WhiteFiber approach to biotech AI colocation
WhiteFiber designs infrastructure as a matched system, not a set of separate parts. In other words, each layer is engineered to work with the others for steady, high performance.
Our AI-native facilities support cabinet densities up to 150 kW with direct liquid cooling. Operational telemetry captures thousands of metrics per second, which gives visibility into all parts of infrastructure performance.
Network design includes both Ethernet and InfiniBand options, so organizations can choose what fits their workload patterns. At the same time, our infrastructure is built to deliver predictable collective performance on either fabric.
Storage uses parallel designs with tiering and policy-driven data movement. Hot tiers deliver 100+ GB/s throughput to keep GPUs supplied with data. Automated lifecycle policies move data across tiers based on how it is used.
The infrastructure connects with WhiteFiber Cloud for burst capacity. This way, organizations can grow beyond dedicated infrastructure when needed, while using the same orchestration tools and security policies.
We maintain SOC 2 Type II certification as the compliance foundation. HIPAA-aligned designs and GxP-ready operating models build on it. In addition, all operations follow documented procedures that support regulatory needs.
FAQ: Biotech AI colocation essentials
Can biotech colocation satisfy HIPAA, GDPR, GxP, and 21 CFR Part 11 requirements?
What GPU utilization patterns make colocation more cost-effective than cloud for biotech?
Should biotech organizations choose InfiniBand or Ethernet for AI colocation networking?
What storage architecture prevents GPU starvation in biotech AI colocation?
.png)
